2013 Anaphylaxis Stroke 
Taming the SRU
FEBRUARY 12, 2024
The patient is agitated on a backboard with C-collar in place. DISCUSSION Epidemiology and Background Rivaroxaban, along with other direct oral anticoagulants (DOACs), has become a mainstay of treatment for pro-thrombotic conditions since 2011. [1] Rivaroxaban and the EINSTEIN clinical trial programme. Blood Coagul Fibrinolysis. Apr; 30(3): 85–95.
Pediatric Emergency Playbook
JUNE 1, 2016
Conversely, is the heart rate too slow – even if the stroke volume is sufficient, if there is severe bradycardia, then cardiac output -- which is in liters/min – is decreased. If so, treat the cause – perhaps this is a distributive problem due to anaphylaxis. 2013 Oct;132(4):663-7. 2013; 41:580-637. 2013; 17:R246.
Expert insights. Personalized for you.
80 
Let's personalize your content